Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis

The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicat...

Full description

Saved in:
Bibliographic Details
Main Authors: Lewis Zhichang Shi, James A. Bonner
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
JAK
Online Access:https://doaj.org/article/186df8d319744d2c830cfb34d6ea2a78
Tags: Add Tag
No Tags, Be the first to tag this record!